Stock listing
0KCC Stock Price, News, Filings & Events — Insight Molecular Diagnostics Inc.
Selected listing: 0KCC · LSE · USD · GB
This page tracks Insight Molecular Diagnostics Inc.'s 0KCC:LSE listing on LSE in USD for GB, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 0KCC:LSE. 0KCC:LSE is the stock-level entry point for investors researching Insight Molecular Diagnostics Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Insight Molecular Diagnostics Inc. (ticker: IMDX) is a public company operating in the American market, with a market capitalization of approximately $153 million. The company focuses on developing innovative diagnostic solutions in the molecular diagnostics field. Its commitment to advancing healthcare through precise and efficient testing positions it as a key player in the industry.
- Ticker
- 0KCC:LSE
- Asset type
- Stock
- Market cap
- $130.9M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- LSE
- Currency
- USD
Insight Molecular Diagnostics Inc. 0KCC:LSE stock context
This page tracks Insight Molecular Diagnostics Inc.'s 0KCC:LSE listing on LSE in USD for GB, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 0KCC:LSE. 0KCC:LSE is the stock-level entry point for investors researching Insight Molecular Diagnostics Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Insight Molecular Diagnostics Inc. (ticker: IMDX) is a public company operating in the American market, with a market capitalization of approximately $153 million. The company focuses on developing innovative diagnostic solutions in the molecular diagnostics field. Its commitment to advancing healthcare through precise and efficient testing positions it as a key player in the industry.
Latest news from Insight Molecular Diagnostics Inc.
iMDx to Participate in Lake Street 10th Annual Best Ideas Growth “BIG10” Conference
September 2, 2026
IMDX Reports Second Quarter 2026 Results and Timely Progress on FDA Review of GraftAssureDx
August 10, 2026
iMDx to Release Second Quarter Results on August 10, 2026 and Attend Needham Virtual MedTech & Diagnostics 1x1 Conference
August 4, 2026
iMDx GraftAssure Assay Guides Use of Potentially Kidney-Graft-Saving Drug in New Lancet Group Publication
July 23, 2026
IMDx Chief Science Officer Ekkehard Schuetz Publishes 200th Research Paper
June 29, 2026
Insight Molecular Diagnostics Inc. earnings calls
Insight Molecular Diagnostics Inc. (IMDX) Q2 2026 Earnings Call
August 10, 2026 · Replay with transcript and chapters
Insight Molecular Diagnostics Inc. (IMDX) Q1 2026 Earnings Call
May 13, 2026 · Replay with transcript and chapters
Insight Molecular Diagnostics Inc. (IMDX) Q4 2025 Earnings Call
March 26, 2026 · Replay with transcript and chapters
Oncocyte Corporation (OCX) Q1 2025 Earnings Call
May 12, 2025 · Replay with transcript and chapters
Oncocyte Corporation (OCX) Q4 2024 Earnings Call
March 25, 2025 · Replay with transcript and chapters
Oncocyte Corporation (OCX) Q3 2024 Earnings Call
November 12, 2024 · Replay with transcript and chapters
Research Insight Molecular Diagnostics Inc.
Insight Molecular Diagnostics Inc. investor report
Review AI stock analysis and investor report context for 0KCC:LSE.
Insight Molecular Diagnostics Inc. company profile
View the public company page for Insight Molecular Diagnostics Inc. on 6ix.
Insight Molecular Diagnostics Inc. news
Read company news and market updates connected to Insight Molecular Diagnostics Inc..
Insight Molecular Diagnostics Inc. investor events
Find investor webinars, events, and replay context for Insight Molecular Diagnostics Inc..
Alternate listings
IMDX:NASDAQ
US · USD
Alternate listing for Insight Molecular Diagnostics Inc.; the primary context on this page is 0KCC:LSE.
IMDX:BOATS
US · USD
Alternate listing for Insight Molecular Diagnostics Inc.; the primary context on this page is 0KCC:LSE.
7OC0:FWB
DE · EUR
Alternate listing for Insight Molecular Diagnostics Inc.; the primary context on this page is 0KCC:LSE.
7OC0:GETTEX
DE · EUR
Alternate listing for Insight Molecular Diagnostics Inc.; the primary context on this page is 0KCC:LSE.
7OC0:MUN
DE · EUR
Alternate listing for Insight Molecular Diagnostics Inc.; the primary context on this page is 0KCC:LSE.
7OC0:TRADEGATE
DE · EUR
Alternate listing for Insight Molecular Diagnostics Inc.; the primary context on this page is 0KCC:LSE.